Black Diamond Therapeutics (BDTX) EBITDA (2018 - 2026)
Black Diamond Therapeutics (BDTX) posted EBITDA of -$11.3 million for Q1 2026, up 36.06% on a QoQ basis from -$17.6 million in Q4 2025, and down 120.65% year-over-year from $54.5 million in Q1 2025.
Black Diamond Therapeutics (BDTX) EBITDA (2018 - 2026) Analysis & Trends
Black Diamond Therapeutics' EBITDA history runs 9 years deep, the most recent figure standing at -$11.3 million for Q1 2026.
- Quarterly EBITDA fell 120.65% year-over-year to -$11.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$53.3 million (down 1230.01% YoY) and the FY2025 annual result came in at $12.5 million, up 115.89% from the prior year.
- EBITDA was -$11.3 million for Q1 2026 at Black Diamond Therapeutics, up from -$17.6 million in the prior quarter.
- Across five years, EBITDA topped out at $54.5 million in Q1 2025 and bottomed at -$25.7 million in Q1 2022.
- A 5-year average of -$15.1 million and a median of -$20.2 million in 2024 frame the typical range for EBITDA.
- Annual changes were most pronounced in 2025 — EBITDA soared 369.34% — and 2026, when it sank 120.65%.
- Black Diamond Therapeutics' EBITDA stood at -$21.9 million in 2022, then advanced by 4.56% to -$20.9 million in 2023, then climbed by 12.37% to -$18.3 million in 2024, then advanced by 3.64% to -$17.6 million in 2025, then jumped by 36.06% to -$11.3 million in 2026.
- Business Quant data shows BDTX's EBITDA at -$11.3 million in Q1 2026, -$17.6 million in Q4 2025, and -$11.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -27.75 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -15.76 Mn |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 249.90 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 1.14 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 642.90 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | -32.68 Mn |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 493.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | -445.22 Mn |
| 10 | Black Diamond Therapeutics | 99.59 Mn | -18.67 Mn | - | -11.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -11.26 Mn |
| Dec 31, 2025 | -17.61 Mn |
| Sep 30, 2025 | -10.98 Mn |
| Jun 30, 2025 | -13.42 Mn |
| Mar 31, 2025 | 54.53 Mn |
| Dec 31, 2024 | -18.28 Mn |
| Sep 30, 2024 | -18.13 Mn |
| Jun 30, 2024 | -22.13 Mn |
| Mar 31, 2024 | -20.25 Mn |
| Dec 31, 2023 | -20.86 Mn |
| Sep 30, 2023 | -24.01 Mn |
| Jun 30, 2023 | -20.03 Mn |
| Mar 31, 2023 | -21.56 Mn |
| Dec 31, 2022 | -21.85 Mn |
| Sep 30, 2022 | -22.12 Mn |
| Jun 30, 2022 | -23.17 Mn |
| Mar 31, 2022 | -25.68 Mn |
| Dec 31, 2021 | -26.08 Mn |
| Sep 30, 2021 | -35.36 Mn |
| Jun 30, 2021 | -34.72 Mn |